Benzinga | Nov 5, 2021 09:22AM EDT

Acceleron Pharma Q3 EPS $(1.16) Down From $(0.66) YoY, Sales $34.20M Up From $22.56M YoY

Acceleron Pharma (NASDAQ:XLRN) reported quarterly losses of $(1.16) per share. This is a 75.76 percent decrease over losses of $(0.66) per share from the same period last year. The company reported $34.20 million in sales this quarter. This is a 51.59 percent increase over sales of $22.56 million the same period last year.